Current Oncology | Editor’s Choice Articles Published in 2023–2024
The goal of the Editor’s Choice Articles project is to promote high-quality articles published in Current Oncology (ISSN: 1718-7729). We are pleased to share the following articles carefully handpicked by the scientific editors of the journal, which we believe will be of interest to you. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/curroncol/editors_choice.
1. “Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan”
by Tomoki Taniguchi, Koji Iinuma, Kei Kawada, Takashi Ishida, Kimiaki Takagi, Masayuki Tomioka, Makoto Kawase, Kota Kawase, Keita Nakane, Yuki Tobisawa et al.
Curr. Oncol. 2024, 31(12), 7914-7923; https://doi.org/10.3390/curroncol31120583
Available online: https://www.mdpi.com/1718-7729/31/12/583
2. “Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response”
by Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, Yoshihiko Tachi, Takeshi Ukai, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka et al.
Curr. Oncol. 2024, 31(10), 6218-6231; https://doi.org/10.3390/curroncol31100463
Available online: https://www.mdpi.com/1718-7729/31/10/463
3. “Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes”
by Marcin Jezierzański, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut and Iwona Gisterek-Grocholska
Curr. Oncol. 2024, 31(7), 3994-4002; https://doi.org/10.3390/curroncol31070296
Available online: https://www.mdpi.com/1718-7729/31/7/296
4. “Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery”
by Hala Muaddi, LaDonna Kearse and Susanne Warner
Curr. Oncol. 2024, 31(4), 2260-2273; https://doi.org/10.3390/curroncol31040167
Available online: https://www.mdpi.com/1718-7729/31/4/167
5. “BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer”
by Sarah Lidagoster, Reuben Ben-David, Benjamin De Leon and John P. Sfakianos
Curr. Oncol. 2024, 31(2), 1063-1078; https://doi.org/10.3390/curroncol31020079
Available online: https://www.mdpi.com/1718-7729/31/2/79
6. “Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma”
by Gaetano Pezzicoli, Federica Ciciriello, Vittoria Musci, Francesco Salonne, Anna Ragno and Mimma Rizzo
Curr. Oncol. 2023, 30(10), 9276-9290; https://doi.org/10.3390/curroncol30100670
Available online: https://www.mdpi.com/1718-7729/30/10/670
7. “Education, Employment, and Financial Outcomes in Adolescent and Young Adult Cancer Survivors—A Systematic Review”
by Aurelia Altherr, Céline Bolliger, Michaela Kaufmann, Daniela Dyntar, Katrin Scheinemann, Gisela Michel, Luzius Mader and Katharina Roser
Curr. Oncol. 2023, 30(10), 8720-8762; https://doi.org/10.3390/curroncol30100631
Available online: https://www.mdpi.com/1718-7729/30/10/631
8. “An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma”
by Thomas Joyce, Sarisha Jagasia, Erdal Tasci, Kevin Camphausen and Andra Valentina Krauze
Curr. Oncol. 2023, 30(9), 8278-8293; https://doi.org/10.3390/curroncol30090601
Available online: https://www.mdpi.com/1718-7729/30/9/601
9. “Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review”
by Caitlin Lazurko, Revital Linder, Kate Pulman, Genevieve Lennox, Tomer Feigenberg, Rouhi Fazelzad, Taymaa May and Tiffany Zigras
Curr. Oncol. 2023, 30(9), 8159-8171; https://doi.org/10.3390/curroncol30090592
Available online: https://www.mdpi.com/1718-7729/30/9/592
10. “Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity”
by Christopher Cluxton and Jarushka Naidoo
Curr. Oncol. 2023, 30(7), 6862-6871; https://doi.org/10.3390/curroncol30070502
Available online: https://www.mdpi.com/1718-7729/30/7/502